Clinical Trial Update: Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial comparing tretinoin 0.025% cream with adapalene 0.1% cream in mild acne vulgaris across Fitzpatrick skin types III-V assessed efficacy, safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene cream 0.1% (adapalene)
• Tretinoin cream 0.025% (tretinoin)

Snippet

Sponsor: Indonesia University | Conditions: Acne Vulgaris | Phase 1, Phase 2 | Status: COMPLETED